# Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial

> **NCT01597557** · NA · COMPLETED · sponsor: **State University of New York at Buffalo** · enrollment: 261 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Magnesium Sulfate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01597557
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01597557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01597557, "Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01597557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*